|
SCIENCE NEWS
Scientists Construct 'Off Switch' for Parkinson Therapy
A common antibiotic can function as an "off switch" for a gene therapy being developed for Parkinson's disease. [University of Florida, Gainesville]
One Factor is Sufficient - Even in Human Cells
After successful experiments with murine cells, German researchers have now reprogrammed human somatic cells with a single factor. [Max Planck Institute for Molecular Biomedicine, Munster]
Finnish Scientists Discover Nerve Growth Factor with Possible Therapeutic Potential in Parkinson's Disease
Researchres report that their latest results show a certain growth factor can be used to halt the progress of damage brought on by a nerve poison and possibly even restore the function of damaged cells. [Academy of Finland, Helsinki]
A Simulator for Brain Surgeons
A new simulator that lets neurosurgeons rehearse before operating--like pilots on a flight simulator--could revolutionize how doctors train for and handle brain surgery.
It's Not All in Your Head: Descending Neural Mechanisms of Placebo-induced Pain Control
A new study reveals that when it comes to pain control, the "placebo effect" involves evolutionarily old pain control pathways in the human brainstem, the part of the brain that is continuous with the spinal cord. [University Medical Center Hamburg-Eppendorf, Hamburg]
Scientists Get First Close Look at Stimulated Brain
With the aid of optical imaging technology, researchers have taken the first look at the cellular level when the brain is electrically prodded. [Harvard School of Medicine, Boston]
Mouse Brain Rewires its Neural Circuits to Recuperate from Damaged Neural Function After Stroke
Japanese researchers have found that after cerebral stroke in one side of the mouse brain, another side of the brain rewires its neural circuits to recuperate from damaged neural function. [National Institute for Physiological Sciences, Aichi]
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
|
|
INDUSTRY NEWS
Connexon Creative Launches Cord Blood News
Cord Blood News is a weekly e-newsletter that keeps members of the cord blood community informed by providing the latest news from all areas of the field, including its science, research, policy, and business.
STEMCELL Technologies Inc. to Host Stem Cell Training Courses
STEMCELL Technologies has announced the schedule for their fall training program including mesenchymal, mammary, neural, hematopoietic, human embryonic and induced pluripotent stem cell biology.
Geron Comments on FDA Hold on Spinal Cord Injury Trial
Geron Corporation recently provided additional comments on the recent clinical hold on its Spinal Cord Injury Investigational New Drug. [Geron, Menlo Park]
BrainStorm Cell Therapeutics Enters into Agreement for Clinical-Grade Stem Cell Production for ALS
BrainStorm Cell Therapeutics Inc. announced recently that it has entered into an agreement with Protein Production Services Ltd. to start Good Manufacturing Practice production of its stem cell therapeutic product. [BrainStorm Cell Therapeutics, Petach Tikvah]
Biotech Startup Hopes Light-activated Nerve Cells will Make it a Northeast Ohio Star
LucCell Inc.'s light switches, which sprang from research at Case Western Reserve University, allow neurons silenced by a spinal cord injury or brain cells malfunctioning due to disease might someday resume working when triggered by flashes of laser light. [LucCell Inc., Cleveland]
Stem Cell Firm Plans Russia's 1st Post-crisis Initial Public Offering
Russia's Stem Cell Institute is seeking to attract some 150 million rubles ($4.75 million) from investors in what would be the country's first initial public offering in more than a year. [The Stem Cell Institute, Moscow]
Drug, Biotech Research Spending Hangs Tough
Corporate America's research spending shrank 4% overall, or $1.9 billion, from the fourth quarter of 2007 through the second quarter of this year, according to data compiled by Capital IQ on 961 U.S. companies. But many health-care companies have boosted their research outlays.
Neurobiological Board Approves Liquidation Plan
Neurobiological, which was already mulling a potential sale of the company or its major assets, said it intends to distribute the majority of its cash to its shareholders. [Neurobiological Technologies, Emeryville]
Indicted Scientist Still Confident of Cloning Authentic Stem Cells
Disgraced cloning scientist Hwang Woo-suk seems to have returned to his old ways.
|
|
EVENTS
World Stem Cell Summit 2009
September 23-25, 2009
Baltimore, United States
TERMIS 2nd World Congress 2009
August 31 - September 3, 2009
Seoul, South Korea
The 2nd Annual Maryland Stem Cell Research Symposium
September 21 2009
Baltimore, United States
Neuroscience 2009
October 17-21, 2009
Chicago, United States
Alzheimer's Disease Beyond Abeta
January 10-15, 2010
Copper Mountain, United States
Molecular Medicine Tri-Conference 2010
February 3-5, 2010
San Francisco, United States
ISSCR 8th Annual Meeting
June 16-19, 2010
San Francisco, United States
|
|
|
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada |
|
|
